Eucrisa Ointment (Crisaborole 2%)

Prescription Topical International (available in India)

Pfizer · International (available in India)

Price: ₹1500–₹3500

Description

Eucrisa contains crisaborole 2%, a topical phosphodiesterase-4 (PDE4) inhibitor. A novel non-steroidal, non-calcineurin inhibitor for mild-to-moderate atopic dermatitis. Works by reducing intracellular cAMP breakdown, thereby reducing inflammatory cytokine production.

Active Compounds

Crisaborole

Active ingredient — PDE4 inhibitor

Concentration: 2%

Hydrocortisone is a low-potency topical corticosteroid identical to endogenous cortisol. It is the m…

Full Ingredient List (INCI)

  • Crisaborole
  • White Petrolatum
  • Propylene Glycol
  • Mono- and Di-glycerides
  • Paraffin
  • Edetate Calcium Disodium
  • Purified Water

Suitable Skin Types

SensitiveDryAll skin types (prescription use)

Key Features

  • Novel PDE4 inhibitor — not a steroid or calcineurin inhibitor
  • No risk of skin atrophy
  • Approved for children ≥2 years
  • Novel mechanism of action
  • Minimal drug interactions
  • Stinging may occur at application site

Usage

Apply a thin layer to affected areas twice daily.

Available Sizes

30 g60 g

Related Conditions

Atopic Dermatitis Topical PDE4 inhibitor for mild-to-moderate eczema

Listing this product is not an endorsement or recommendation. DermaBuddy has no financial relationship with Pfizer or any retailer. Always patch-test new products and consult a dermatologist if you have specific skin concerns.